Development and application of TCM body regulating protection scheme for the convalescent population of novel coronavirus pneumonia (COVID-19)
- Conditions
- ovel Coronavirus Pneumonia (COVID-19)
- Registration Number
- ITMCTR2000003188
- Lead Sponsor
- Beijing University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. Meet the history of COVID-19 confirmed in accordance with the diagnosis and treatment plan of COVID-19(trial seventh edition);
2. Meet the discharge standards of COVID-19(trial seventh edition);
3. Meet the diagnosis standard of qi deficiency and phlegm stasis syndrome;
4. Patients aged 18-70 years old, 28 days after discharge, still have abnormal manifestations on lung CT;
5. Patients willing to sign informed consent.
1. Patients with primary and secondary cardiovascular, cerebrovascular, renal, endocrine, neurological and blood system diseases, tumors and tuberculosis;
2. Patients who have participated in or are participating in other clinical trials within one month;
3. Patients with mental disorders who can not express their feelings;
4. There are other situations that are not suitable to be included in the study.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method